Deise Uema
University of São Paulo
4 Papers
Deise Uema is an academic researcher from University of São Paulo. The author has contributed to research in topics: Cronbach's alpha & Cancer. The author has an hindex of 1, co-authored 4 publications.
Chat about Author
Papers
Validation of questionnaire on the Spiritual Needs Assessment for Patients (SNAP) questionnaire in Brazilian Portuguese
Diego de Araujo Toloi,Deise Uema,Felipe Yu Matsushita,Paulo Antonio da Silva Andrade,Tiago Pugliese Branco,Fabiana Tomie Becker de Carvalho Chino,Raquel Bezerra Guerra,Tulio Eduardo Flesch Pfiffer,Toshio Chiba,Rodrigo Santa Cruz Guindalini,Daniel P. Sulmasy,Rachel P. Riechelmann +11 more
TL;DR: The SNAP questionnaire translated into Brazilian Portuguese is adequately reliable and consistent and allows adequate access to spiritual needs and can help patient care.
Chemotherapy in a Patient With G6PD Deficiency and Advanced Testicular Cancer
Deise Uema,Denyei Nakazato,Cheng Tzu Yen,Eduardo Perrone,Diogo Assed Bastos,Gilberto de Castro +5 more
TL;DR: The case of a young man with advanced testicular germ cell tumor treated with cisplatin-based chemotherapy (bleomycin, etoposide and cisPlatin) and data regarding the use and safety of chemotherapy treatments in this population in the literature is extremely scarce are described.
3
Phase IV Trials: Interventional and Non-interventional Studies
Deise Uema,Cheng Tzu Yen,Axel Hinke,Gilberto de Castro +3 more
- 01 Jan 2018
TL;DR: Phase IV trials, studies conducted in the post-marketing scenario, are usually performed with a large number of patients and heterogeneous populations and can be used to increase the generalizability of findings from phase III trials, to evaluate uncommon adverse events, and sometimes to assess cost-effectiveness.
Health resource utilisation by patients with neuroendocrine tumours with or without carcinoid heart disease: a multinational study.
Hugo Tanaka,Deise Uema,Juliana Florinda M. Rego,Rui F. Weschenfelder,Nathalia D'Agustini,Duilio Reis da Rocha Filho,Juan Manuel O'Connor,Romina Luca,Jose Eduardo Nuñez,Milton Jose De Barros E. Silva,Rachel P. Riechelmann +10 more
TL;DR: NET patients with CHD present higher HRU independently of other clinical factors or health system, and effectively treating carcinoid syndrome, and likely delaying the onset of CHD may potentially reduce the amount of HRU by these patients.